National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Clinical Trials and Translational Research Advisory Committee

Presentations from the 25th Meeting Held November 12, 2014
(Presentation File Format - PDF --> Get Adobe Reader)

November 12
NIH VIDEOCAST  

DEPUTY DIRECTOR'S UPDATE  
Deputy Director's Update
Cancer Clinical Investigator Team Leadership Awardees (CCITLA) 2009 2014
2014 Administrative Supplement Announcement for the CCITLA Program
Dr. Doroshow

LEGISLATIVE UPDATE  
Legislative Update
Legislative Report
Ms. Erickson

NCI INTRAMURAL LONG TERM PLANNING  
NCI Intramural Long Term Planning
Dr. Helman

NCI's EVOLVING LATE PHASE CLINICAL TRIALS SYSTEM  
Overview
NCI National Clinical Trials Network (NCTN)
Setting Strategic Priorities for NCTN
NCI Community Oncology Research Program (NCORP)
Community Oncology Investigator Perspective
Dr. Doroshow
Dr. Mooney
Dr. Abrams
Dr. McCaskill-Stevens
Dr. Kuebler

NCI's DRUG COMBINATION PROJECT  
Cell-based Screens of Drug Combination at NCI Dr. Holbeck

EXPERIMENTAL THERAPEUTICS CLINICAL TRIALS NETWORK (ET-CTN)  
Experimental Therapeuticss Clinical Trials Network (ET-CTN) - Overview
ET-CTN Drug-Specific Project Teams: Clinical/Translational Researcher Perspective
Dr. Ivy
Dr. Shapiro

ACCRUAL TO NCI EARLY PHASE STUDIES  
Accrual to NCI Early Phase Studies Dr. Massett

NEW BUSINESS AND ANNOUNCEMENTS Dr. Abbruzzese

Top